Furberg, Full Drug Safety Committee To Be Present At COX-2 Meeting
Executive Summary
Wake Forest University epidemiologist Curt Furberg will participate with FDA's full Drug Safety & Risk Management Advisory Committee in the upcoming review of the COX-2 inhibitor therapeutic class